Jeong Bae Park Selected Research

fimasartan

1/2017	Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study.
7/2016	Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS Study.
5/2016	Clinic and Home Blood Pressure Lowering Effect of an Angiotensin Receptor Blocker, Fimasartan, in Postmenopausal Women with Hypertension.
1/2016	Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension.
5/2014	The Efficacy of Fimasartan for Cardiovascular Events and Metabolic Syndrome (K-MetS Study): Rationale, Design and Participant Characteristics.
2/2013	Safety and efficacy of fimasartan in patients with arterial hypertension (Safe-KanArb study): an open-label observational study.
6/2012	Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeong Bae Park Research Topics

Disease

22	Hypertension (High Blood Pressure) 11/2020 - 01/2002
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 08/2006
3	Atherosclerosis 11/2016 - 10/2012
3	Stroke (Strokes) 05/2015 - 01/2002
3	Diabetes Mellitus 05/2015 - 10/2011
3	Coronary Disease (Coronary Heart Disease) 05/2013 - 04/2004
2	Hemorrhage 02/2016 - 08/2015
2	Peptic Ulcer (Peptic Ulcers) 02/2016 - 08/2015
2	Infections 09/2015 - 05/2013
2	Fatty Liver 01/2015 - 11/2013
2	Inflammation (Inflammations) 01/2015 - 10/2012
2	Cardiomegaly (Heart Hypertrophy) 04/2004 - 01/2004
2	Pre-Eclampsia (Preeclampsia) 04/2004 - 07/2002
2	Fibrosis (Cirrhosis) 01/2004 - 02/2002
2	Hypertrophy 01/2004 - 02/2002
1	Pregnancy Complications 01/2019
1	Out-of-Hospital Cardiac Arrest 06/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2016
1	Hyperuricemia 07/2016
1	Sepsis (Septicemia) 01/2016
1	Critical Illness (Critically Ill) 01/2016
1	Poisoning 01/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2015
1	Prediabetic State (Prediabetes) 05/2015
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2015
1	Isolated Systolic Hypertension 04/2015
1	Neoplasms (Cancer) 03/2015
1	Insulin Resistance 01/2015
1	Essential Hypertension 10/2014
1	Heart Failure 05/2014
1	Myocardial Infarction 05/2014
1	Dyslipidemias (Dyslipidemia) 05/2014
1	Hypertriglyceridemia 05/2014
1	Hypochondriasis 12/2013
1	Adenoma (Adenomas) 08/2013
1	Polyps 08/2013
1	Cross Infection (Nosocomial Infection) 07/2013
1	Weight Loss (Weight Reduction) 05/2013
1	Type 2 Diabetes Mellitus (MODY) 10/2012
1	Vascular Diseases (Vascular Disease) 10/2012
1	Intussusception 12/2011
1	Rare Diseases (Rare Disease) 12/2011
1	Carotid Artery Diseases 04/2004
1	Eclampsia 07/2002

Drug/Important Bio-Agent (IBA)

7	fimasartanIBA 01/2017 - 06/2012
5	Angiotensin Receptor AntagonistsIBA 01/2019 - 02/2013
5	Antihypertensive Agents (Antihypertensives)IBA 05/2016 - 01/2010
4	SaltsIBA 05/2013 - 01/2002
4	AldosteroneIBA 12/2008 - 02/2002
3	CalciumIBA 11/2020 - 10/2012
3	Biomarkers (Surrogate Marker)IBA 11/2016 - 08/2015
3	Glucose (Dextrose)FDA LinkGeneric 05/2014 - 10/2011
2	Valsartan (Vals)FDA Link 01/2016 - 10/2014
2	Nifedipine (Adalat)FDA LinkGeneric 01/2016 - 10/2014
2	AlbuminsIBA 01/2015 - 04/2004
2	C-Reactive ProteinIBA 01/2015 - 04/2004
2	Adenosine Triphosphate (ATP)IBA 06/2009 - 08/2006
2	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2008 - 01/2004
2	acetovanillone (apocynin)IBA 12/2008 - 01/2004
2	MineralocorticoidsIBA 01/2004 - 02/2002
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Uric Acid (Urate)IBA 07/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2016
1	Lipocalin-2IBA 01/2016
1	Contraceptive Agents (Contraceptives)IBA 05/2015
1	LipidsIBA 05/2015
1	CationsIBA 03/2015
1	AdiponectinIBA 01/2015
1	CreatinineIBA 01/2015
1	Indicators and Reagents (Reagents)IBA 01/2015
1	AdipokinesIBA 01/2015
1	Pharmaceutical PreparationsIBA 05/2014
1	HDL CholesterolIBA 05/2014
1	omega-Chloroacetophenone (Mace)IBA 05/2014
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 12/2013
1	Cadherins (E-Cadherin)IBA 08/2013
1	Ferritins (Ferritin)IBA 10/2012
1	IronIBA 10/2012
1	Transferrin (beta 2 Transferrin)IBA 10/2012
1	Insulin (Novolin)FDA Link 06/2009
1	Losartan (Cozaar)FDA LinkGeneric 12/2008
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2008
1	CholesterolIBA 08/2006
1	Interleukin-6 (Interleukin 6)IBA 04/2004
1	AngiotensinogenIBA 04/2004
1	Fibrinogen (Factor I)FDA Link 04/2004
1	HDL LipoproteinsIBA 04/2004
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2004
1	trichrome stainIBA 01/2004
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2004
1	Angiotensin IIIBA 08/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2003

Therapy/Procedure

4	Therapeutics 09/2015 - 02/2013
2	Drug Therapy (Chemotherapy) 05/2015 - 05/2015
2	Endoscopes 07/2013 - 05/2013
1	Cardiopulmonary Resuscitation (CPR) 06/2017
1	Aftercare (After-Treatment) 01/2017
1	Appendectomy 12/2011
1	Tocolysis 07/2002